Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bartlett J. G., Breiman R. F., Mandell L. A., File T. M., Jr Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America. Clin Infect Dis. 1998 Apr;26(4):811–838. doi: 10.1086/513953. [DOI] [PubMed] [Google Scholar]
- Bauernfeind A. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin. J Antimicrob Chemother. 1997 Nov;40(5):639–651. doi: 10.1093/jac/40.5.639. [DOI] [PubMed] [Google Scholar]
- Bryskier A., Chantot J. F. Classification and structure-activity relationships of fluoroquinolones. Drugs. 1995;49 (Suppl 2):16–28. doi: 10.2165/00003495-199500492-00005. [DOI] [PubMed] [Google Scholar]
- Ernst M. E., Ernst E. J., Klepser M. E. Levofloxacin and trovafloxacin: the next generation of fluoroquinolones? Am J Health Syst Pharm. 1997 Nov 15;54(22):2569–2584. doi: 10.1093/ajhp/54.22.2569. [DOI] [PubMed] [Google Scholar]
- Hooper D. C. Clinical applications of quinolones. Biochim Biophys Acta. 1998 Oct 1;1400(1-3):45–61. doi: 10.1016/s0167-4781(98)00127-4. [DOI] [PubMed] [Google Scholar]
- Jones R. N., Kehrberg E. N., Erwin M. E. Resistance among important pathogens and the antimicrobial activity of parenteral fluoroquinolones at 43 US medical centres. Drugs. 1995;49 (Suppl 2):179–181. doi: 10.2165/00003495-199500492-00033. [DOI] [PubMed] [Google Scholar]
- Lietman P. S. Fluoroquinolone toxicities. An update. Drugs. 1995;49 (Suppl 2):159–163. doi: 10.2165/00003495-199500492-00026. [DOI] [PubMed] [Google Scholar]
- Lomaestro B. M., Bailie G. R. Absorption interactions with fluoroquinolones. 1995 update. Drug Saf. 1995 May;12(5):314–333. doi: 10.2165/00002018-199512050-00004. [DOI] [PubMed] [Google Scholar]
- Ramsey B. W. Management of pulmonary disease in patients with cystic fibrosis. N Engl J Med. 1996 Jul 18;335(3):179–188. doi: 10.1056/NEJM199607183350307. [DOI] [PubMed] [Google Scholar]
- Stratton C. W. Avoiding fluoroquinolone resistance. Strategies for primary care practice. Postgrad Med. 1997 Mar;101(3):247-50, 255. doi: 10.3810/pgm.1997.03.186. [DOI] [PubMed] [Google Scholar]
- Suh B., Lorber B. Quinolones. Med Clin North Am. 1995 Jul;79(4):869–894. doi: 10.1016/s0025-7125(16)30044-x. [DOI] [PubMed] [Google Scholar]
- Wexler H. M., Molitoris E., Molitoris D., Finegold S. M. In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria. Antimicrob Agents Chemother. 1996 Sep;40(9):2232–2235. doi: 10.1128/aac.40.9.2232. [DOI] [PMC free article] [PubMed] [Google Scholar]